Synthesis of 3-O-methylviridicatin analogues with improved anti-TNF-α properties
Authors:
- Helena TabakaHTHelena Tabaka
- Jean PelusoJPJean Peluso
- Ludivine FetzerLFLudivine Fetzer
- Can NebigilCNCan Nebigil
- Serge DumontSDSerge Dumont
- Christian D. MullerChristian D. Muller
- Laurent DésaubryLDLaurent Désaubry
- 1 October 2007
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 17 (20) , 5523-5524
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Problems encountered during anti-tumour necrosis factor therapyBest Practice & Research Clinical Rheumatology, 2006
- Modulating TNF-α signaling with natural productsDrug Discovery Today, 2006
- Celastrol inhibits pro-inflammatory cytokine secretion in Crohn’s disease biopsiesBiochemical and Biophysical Research Communications, 2004
- Camps reaction for the synthesis of 3-RS-4-arylquinolin-2-onesRussian Chemical Bulletin, 2003
- Anti-TNF-α therapies: the next generationNature Reviews Drug Discovery, 2003
- The synthesis and structure–activity relationships of 4-aryl-3-aminoquinolin-2-ones: a new class of calcium-Dependent, large conductance, potassium (maxi-K) channel openers targeted for post-stroke neuroprotectionBioorganic & Medicinal Chemistry Letters, 2002
- Isolation and Characterization of the Fungal Metabolite 3-O-Methylviridicatin as an Inhibitor of Tumour Necrosis Factor α-Induced Human Immunodeficiency Virus ReplicationAntiviral Chemistry and Chemotherapy, 1998
- 3-Amino-2(1H)-quinolones by Cyclizaion of N-Acylated Anthranilic Acid DerivativesHETEROCYCLES, 1997
- The captodative effectAccounts of Chemical Research, 1985